| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.012 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |